Fraunhofer IPMS is continuously expanding the application range of scanner mirror technology with novel and patented design solutions and technology modules as well as the integration of artificial intelligence.

Scientists at the Fraunhofer Institute for Biomedical Engineering IBMT have been working with international partners to develop a technology platform to help relieve the symptoms of muscle tremors.

Developing pioneering technology solutions and bringing them into application - that is the goal of Fraunhofer Institute for Photonic Microsystems IPMS.

Experts from the Fraunhofer-Gesellschaft will be providing insights into their current work at DMEA 2023 in Berlin at booth D107 in Hall 2.2.

Developed by the innovation cluster INTAKT, this new generation of interactive microimplants can act as a stimulus in cases of tinnitus or digestive tract disorders or help a person’s hand to regain the ability to grip.

With its innovative micro-electro-mechanical systems and micro-opto-electro-mechanical systems, the institute opens up new applications through improved properties and additional functions, such as smaller dimensions, greater energy efficiency and higher performance.

To prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells. However, the availability of cells like these has been limited to date. Now, Fraunhofer researchers have succeeded in scaling the production of customized immune cells from laboratory up to industrial level.

The remobilization of finger joints that have been damaged by illness or injury is an emerging market in the field of demand-driven patient care. The FingerKIt consortium, which brings together five Fraunhofer institutes, uses AI to develop personalized 3D-printed joint implants so that these delicate finger parts can be replaced when necessary.